Loading...
Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial
CONTEXT: Mesenchymal stem cells (MSCs) are under evaluation as a therapy for ischemic cardiomyopathy (ICM). Both autologous and allogeneic MSC therapies are possible; however, their safety and efficacy have not been compared. OBJECTIVE: To test whether allogeneic MSCs are as safe and effective as au...
Na minha lista:
Udgivet i: | JAMA |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2012
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4762261/ https://ncbi.nlm.nih.gov/pubmed/23117550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2012.25321 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|